Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 6, 2023

Response to Tony Badrick regarding “Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205–212 by”

  • Wayne J. Dimech ORCID logo EMAIL logo , Giuseppe A. Vincini ORCID logo , Mario Plebani ORCID logo , Giuseppe Lippi ORCID logo , James H. Nichols and Oswald Sonntag

Corresponding author: Wayne J. Dimech, Scientific and Business Relations Manager, National Serology Reference Laboratory, Australia, 4th Floor Healy Building, 41 Victoria Parade, Fitzroy, 3065, Australia, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Badrick, T. Letter to the Editor regarding the article by Wayne J. Dimech, Giuseppe A. Vincini, Mario Plebani, Giuseppe Lippi, James H. Nichols, and Oswald Sonntag. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023;61:205–12. https://doi.org/10.1515/cclm-2018-1276.Search in Google Scholar PubMed

2. Dimech, WJ, Vincini, GA, Plebani, M, Lippi, G, Nichols, JH, Sonntag, O. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023;61:205–12. https://doi.org/10.1515/cclm-2022-0986.Search in Google Scholar PubMed

3. Badrick, T, Parvin, C. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8.Search in Google Scholar

4. Dimech, W, Karakaltsas, M, Vincini, GA. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8. https://doi.org/10.1515/cclm-2018-0351.Search in Google Scholar PubMed

5. Dimech, W. The standardization and control of serology and nucleic acid testing for infectious diseases. Clin Microbiol Rev 2021;2021:34. https://doi.org/10.1128/cmr.00035-21.Search in Google Scholar

6. Plebani, M, Gillery, P, Greaves, RF, Lackner, KJ, Lippi, G, Melichar, B, et al.. Rethinking internal quality control: the time is now. Clin Chem Lab Med 2022;60:1316–7. https://doi.org/10.1515/cclm-2022-0587.Search in Google Scholar PubMed

7. CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions. Wayne PA: Clinical and Laboratory Standards Institute; 2016.Search in Google Scholar

8. Public Health England (PHE). UK standards for microbiology investigations: UK standards for microbiology investigations. London, UK: Standards Unit National Infection Service, Public Health England; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1005438/Q_2i8.pdf.Search in Google Scholar

9. Dimech, W, Vincini, G, Karakaltsas, M. Determination of quality control limits for serological infectious disease testing using historical data. Clin Chem Lab Med 2015;53:329–36. https://doi.org/10.1515/cclm-2014-0546.Search in Google Scholar PubMed

10. Dimech, WJ, Vincini, GA, Cabuang, LM, Wieringa, M. Does a change in quality control results influence the sensitivity of an anti-HCV test? Clin Chem Lab Med 2020;58:1372–80. https://doi.org/10.1515/cclm-2020-0031.Search in Google Scholar PubMed

Received: 2023-02-21
Accepted: 2023-02-22
Published Online: 2023-03-06
Published in Print: 2023-07-26

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 9.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2023-0178/html
Scroll to top button